191 related articles for article (PubMed ID: 30422238)
21. The c.553G>T Genetic Variant of the APOA5 Gene and Altered Triglyceride Levels in the Asian Population: A Meta-Analysis of Case-Control Studies.
He H; Lei L; Chen E; Dong J; Zhang K; Yang J
Genet Test Mol Biomarkers; 2016 Dec; 20(12):758-765. PubMed ID: 27813673
[TBL] [Abstract][Full Text] [Related]
22. Allelic variation in ApoC3, ApoA5 and LPL genes and first and second generation antipsychotic effects on serum lipids in patients with schizophrenia.
Smith RC; Segman RH; Golcer-Dubner T; Pavlov V; Lerer B
Pharmacogenomics J; 2008 Jun; 8(3):228-36. PubMed ID: 17726453
[TBL] [Abstract][Full Text] [Related]
23. Interactions of Environmental Factors and APOA1-APOC3-APOA4-APOA5 Gene Cluster Gene Polymorphisms with Metabolic Syndrome.
Wu Y; Yu Y; Zhao T; Wang S; Fu Y; Qi Y; Yang G; Yao W; Su Y; Ma Y; Shi J; Jiang J; Kou C
PLoS One; 2016; 11(1):e0147946. PubMed ID: 26824674
[TBL] [Abstract][Full Text] [Related]
24. The impact of APOA5, APOB, APOC3 and ABCA1 gene polymorphisms on ischemic stroke: Evidence from a meta-analysis.
Au A; Griffiths LR; Irene L; Kooi CW; Wei LK
Atherosclerosis; 2017 Oct; 265():60-70. PubMed ID: 28865324
[TBL] [Abstract][Full Text] [Related]
25. APOA5 genetic and epigenetic variability jointly regulate circulating triacylglycerol levels.
Oliva I; Guardiola M; Vallvé JC; Ibarretxe D; Plana N; Masana L; Monk D; Ribalta J
Clin Sci (Lond); 2016 Nov; 130(22):2053-2059. PubMed ID: 27613158
[TBL] [Abstract][Full Text] [Related]
26. Identifying functional non-coding variants in APOA5/A4/C3/A1 gene cluster associated with coronary heart disease.
Cui G; Tian M; Hu S; Wang Y; Wang DW
J Mol Cell Cardiol; 2020 Jul; 144():54-62. PubMed ID: 32437778
[TBL] [Abstract][Full Text] [Related]
27. Plasma apolipoprotein A5 and triglycerides in type 2 diabetes.
Dallinga-Thie GM; van Tol A; Hattori H; van Vark-van der Zee LC; Jansen H; Sijbrands EJ;
Diabetologia; 2006 Jul; 49(7):1505-11. PubMed ID: 16752169
[TBL] [Abstract][Full Text] [Related]
28. Association of apolipoprotein A-V concentration with apolipoprotein A5 gene -1131T>C polymorphism and fasting triglyceride levels.
Kim JY; Kim OY; Paik JK; Lee SH; Lee JH
J Clin Lipidol; 2013; 7(2):94-101. PubMed ID: 23415427
[TBL] [Abstract][Full Text] [Related]
29. Long-term efficacy and safety of bexarotene for Japanese patients with cutaneous T-cell lymphoma: The results of a phase 2 study (B-1201).
Hamada T; Tokura Y; Sugaya M; Ohtsuka M; Tsuboi R; Nagatani T; Kiyohara E; Tani M; Setoyama M; Matsushita S; Kawai K; Yonekura K; Saida T; Iwatsuki K
J Dermatol; 2019 Jul; 46(7):557-563. PubMed ID: 31090237
[TBL] [Abstract][Full Text] [Related]
30. Modeling the influence of APOC3, APOE, and TNF polymorphisms on the risk of antiretroviral therapy-associated lipid disorders.
Tarr PE; Taffé P; Bleiber G; Furrer H; Rotger M; Martinez R; Hirschel B; Battegay M; Weber R; Vernazza P; Bernasconi E; Darioli R; Rickenbach M; Ledergerber B; Telenti A;
J Infect Dis; 2005 May; 191(9):1419-26. PubMed ID: 15809899
[TBL] [Abstract][Full Text] [Related]
31. SNPs at the APOA5 gene account for the strong association with hypertriglyceridaemia at the APOA5/A4/C3/A1 locus on chromosome 11q23 in the Northern Irish population.
Wright WT; Young IS; Nicholls DP; Patterson C; Lyttle K; Graham CA
Atherosclerosis; 2006 Apr; 185(2):353-60. PubMed ID: 16125709
[TBL] [Abstract][Full Text] [Related]
32. APOC3/A5 haplotypes, lipid levels, and risk of myocardial infarction in the Central Valley of Costa Rica.
Ruiz-Narváez EA; Yang Y; Nakanishi Y; Kirchdorfer J; Campos H
J Lipid Res; 2005 Dec; 46(12):2605-13. PubMed ID: 16192625
[TBL] [Abstract][Full Text] [Related]
33. Association between plasma lipid parameters and APOC3 genotypes in Brazilian subjects: effect of gender, smoking and APOE genotypes.
Fiegenbaum M; de Andrade FM; Hutz MH
Clin Chim Acta; 2007 May; 380(1-2):175-81. PubMed ID: 17367769
[TBL] [Abstract][Full Text] [Related]
34. Optimizing bexarotene therapy for cutaneous T-cell lymphoma.
Talpur R; Ward S; Apisarnthanarax N; Breuer-Mcham J; Duvic M
J Am Acad Dermatol; 2002 Nov; 47(5):672-84. PubMed ID: 12399758
[TBL] [Abstract][Full Text] [Related]
35. Absence of modulation of CD4+CD25 regulatory T cells in CTCL patients treated with bexarotene.
Knol AC; Quéreux G; Brocard A; Ballanger F; Khammari A; Nguyen JM; Dréno B
Exp Dermatol; 2010 Aug; 19(8):e95-102. PubMed ID: 19845755
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of the efficacy of the combination of oral bexarotene and methotrexate for the treatment of early stage treatment-refractory cutaneous T-cell lymphoma.
Kannangara AP; Levitan D; Fleischer AB
J Dermatolog Treat; 2009; 20(3):169-76. PubMed ID: 19016373
[TBL] [Abstract][Full Text] [Related]
37. Impact of apolipoprotein A5 (APOA5) polymorphisms on serum triglyceride levels in schizophrenic patients under long-term atypical antipsychotic treatment.
Hong CJ; Chen TT; Bai YM; Liou YJ; Tsai SJ
World J Biol Psychiatry; 2012 Jan; 13(1):22-9. PubMed ID: 21375366
[TBL] [Abstract][Full Text] [Related]
38. APOA5 genetic variants are markers for classic hyperlipoproteinemia phenotypes and hypertriglyceridemia.
Wang J; Ban MR; Kennedy BA; Anand S; Yusuf S; Huff MW; Pollex RL; Hegele RA
Nat Clin Pract Cardiovasc Med; 2008 Nov; 5(11):730-7. PubMed ID: 18779834
[TBL] [Abstract][Full Text] [Related]
39. APOA5 and APOA1 polymorphisms are associated with triglyceride levels in Mexican children.
Suárez-Sánchez F; Klunder-Klunder M; Valladares-Salgado A; Gómez-Zamudio J; Peralta-Romero J; Meyre D; Burguete-García A; Cruz M
Pediatr Obes; 2017 Aug; 12(4):330-336. PubMed ID: 27171122
[TBL] [Abstract][Full Text] [Related]
40. Rare and common variants in LPL and APOA5 in Thai subjects with severe hypertriglyceridemia: A resequencing approach.
Khovidhunkit W; Charoen S; Kiateprungvej A; Chartyingcharoen P; Muanpetch S; Plengpanich W
J Clin Lipidol; 2016; 10(3):505-511.e1. PubMed ID: 27206937
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
